Department of Physiology, Morehouse School of Medicine, Atlanta, GA, 30310, USA.
Department of Obstetrics and Gynecology, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA, 30310, USA.
Inflammation. 2023 Dec;46(6):2055-2070. doi: 10.1007/s10753-023-01862-x. Epub 2023 Jun 30.
Endometriosis is a common gynecological inflammatory disorder characterized by immune system dysregulation, which is involved in lesion initiation and progression. Studies have demonstrated that several cytokines are associated with the evolution of endometriosis, including tumor necrosis factor-α (TNFα). TNFα is a non-glycosylated cytokine protein with potent inflammatory, cytotoxic, and angiogenic potential. In the current study, we examined the ability of TNFα to induce dysregulation of microRNAs (miRNAs) linked to NFkB signaling pathways, thus contributing to the pathogenesis of endometriosis. Using RT-qPCR, the expression of several miRNAs was quantified in primary cells derived from eutopic endometrium of endometriosis subjects (EESC) and normal endometrial stromal cells (NESC), and also TNFα-treated NESCs. The phosphorylation of the pro-inflammatory molecule NF-κB and the candidates of the survival pathways PI3K, AKT, and ERK was measured by western blot analysis. The elevated secretion of TNFα in EESCs downregulates the expression level of several miRNAs significantly in EESCs compared to NESCs. Also, treatment of NESCs with exogenous TNFα significantly reduced the expression of miRNAs in a dose-dependent manner to levels similar to EESCs. In addition, TNFα significantly increased the phosphorylation of the PI3K, AKT, ERK, and NF-κB signaling pathways. Notably, treatment with curcumin (CUR, diferuloylmethane), an anti-inflammatory polyphenol, significantly increased the expression of dysregulated miRNAs in EESC in a dose-dependent manner. Our findings demonstrate that TNFα is upregulated in EESCs, which subsequently dysregulates the expression of miRNAs, contributing to the pathophysiology of endometriotic cells. CUR effectively inhibits the expression of TNFα, subsequently altering miRNA levels and suppressing the phosphorylation of AKT, ERK, and NF-κB.
子宫内膜异位症是一种常见的妇科炎症性疾病,其特征为免疫系统失调,涉及病变的起始和进展。研究表明,几种细胞因子与子宫内膜异位症的演变有关,包括肿瘤坏死因子-α(TNFα)。TNFα 是一种非糖基化细胞因子蛋白,具有强大的炎症、细胞毒性和血管生成潜力。在本研究中,我们研究了 TNFα 诱导与 NFkB 信号通路相关的 microRNAs(miRNAs)失调的能力,从而促进子宫内膜异位症的发病机制。使用 RT-qPCR,定量检测了子宫内膜异位症患者(EESC)和正常子宫内膜基质细胞(NESC)的原代细胞中几种 miRNAs 的表达,以及 TNFα 处理的 NESC。通过 Western blot 分析测量了促炎分子 NF-κB 的磷酸化和生存途径 PI3K、AKT 和 ERK 的候选物。EESC 中 TNFα 的升高分泌水平与 NESC 相比显著下调了 EESC 中几种 miRNAs 的表达水平。此外,外源性 TNFα 处理 NESC 以剂量依赖性方式显著降低了 miRNAs 的表达水平,使其与 EESC 相似。此外,TNFα 显著增加了 PI3K、AKT、ERK 和 NF-κB 信号通路的磷酸化。值得注意的是,用姜黄素(CUR,二芳基甲烷)处理,一种抗炎多酚,以剂量依赖性方式显著增加了 EESC 中失调 miRNA 的表达。我们的研究结果表明,TNFα 在 EESC 中上调,随后失调 miRNA 的表达,导致子宫内膜异位细胞的病理生理学改变。CUR 有效抑制 TNFα 的表达,随后改变 miRNA 水平并抑制 AKT、ERK 和 NF-κB 的磷酸化。